
RadiantGraph, a San Francisco, CA-based platform that uses machine learning and artificial intelligence to drive consumer engagement for health plans, raised $5 million in seed funding.
SaaS Investors
The round was led by True Ventures and XYZ Ventures, with participation from Remus Capital.
Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early stage technology startups. With more than $3.8 billion under management, True provides seed and Series A financing to entrepreneurs in some of today's fastest growing markets.
XYZ Venture Capital is a venture firm that invests in early-stage founders to help them go faster. Founded in 2017, XYZ aims to support entrepreneurs in building enduring companies in fintech, enterprise and tech-forgotten industries like insurance and the public sector.
RadiantGraph Use of Funds
The company will use the funds used to accelerate growth, which includes partnering with new healthcare organizations, and advancing their enterprise health and health plan product offerings.
About RadiantGraph
RadiantGraph is on a mission to make healthcare more accessible and easier for all of us as consumers. The company’s AI platform helps leading healthcare organizations build deeper and richer connections with their consumers, driving personalized engagement and clinical outcomes. The platform uses AI and ML to create tailored consumer healthcare experiences by translating data, including medical claims, medication history, and biometric data.
Funding Details
Company: RadiantGraph, Inc.
Raised: $5 million
Round: Seed Round
Funding Month: October 2023
Lead Investors: True Ventures and XYZ Ventures
Additional Investor: Remus Capital
Company website: https://www.radiantgraph.com/
Software Category: Health Solutions
Source: https://www.prnewswire.com/news-releases/radiantgraph-launches-with-5-million-round-to-bring-ai-personalization-to-health-plans-and-enterprise-health-301966812.html